Peapack Gladstone Financial Corp Edwards Lifesciences Corp Transaction History

Peapack Gladstone Financial Corp

$6.51 Billion
Q2 2024

A detailed history of Peapack Gladstone Financial Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 141,219 shares of EW stock, worth $9.57 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

141,219

Previous 134,201 5.23%

Holding current value

$9.57 Million

Previous $12.8 Million 1.7%

% of portfolio

0.2%

Previous 0.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $591,617 - $661,867	7,018 Added 5.23%	141,219 $13 Million
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $2.45 Million - $3.23 Million	33,763 Added 33.62%	134,201 $12.8 Million
Q4 2023 Feb 13, 2024	BUY	$61.71 - $77.76 $631,416 - $795,640	10,232 Added 11.34%	100,438 $7.66 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $516,343 - $695,961	-7,453 Reduced 7.63%	90,206 $6.25 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $1.1 Million - $1.27 Million	13,483 Added 16.02%	97,659 $9.21 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $1.56 Million - $1.78 Million	-21,027 Reduced 19.99%	84,176 $6.96 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $2.61 Million - $3.34 Million	38,222 Added 57.06%	105,203 $7.85 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $861,095 - $1.12 Million	10,454 Added 18.49%	66,981 $5.53 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $2.7 Million - $4.01 Million	31,226 Added 123.42%	56,527 $5.38 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $434,451 - $546,856	4,261 Added 20.25%	25,301 $2.98 Million
Q4 2021 Feb 15, 2022	BUY	$106.37 - $130.68 $246,140 - $302,393	2,314 Added 12.36%	21,040 $2.73 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $297,615 - $354,993	2,892 Added 18.26%	18,726 $2.12 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $432,446 - $540,352	5,158 Added 48.31%	15,834 $1.64 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $1.36 Million - $1.57 Million	-17,336 Reduced 61.89%	10,676 $893,000
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $39,071 - $49,720	-545 Reduced 1.91%	28,012 $2.56 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $1.48 Million - $1.92 Million	21,954 Added 332.49%	28,557 $2.28 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $251,852 - $336,810	4,377 Added 196.63%	6,603 $456,000
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $7,861 - $12,150	150 Added 7.23%	2,226 $420,000
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $3,800 - $4,350	-53 Reduced 2.49%	2,076 $484,000
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $9,232 - $11,314	-150 Reduced 6.58%	2,129 $468,000
Q2 2019 Aug 15, 2019	BUY	$55.74 - $64.41 $64,714 - $74,780	1,161 Added 103.85%	2,279 $421,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $53,541 - $71,607	1,118 New	1,118 $214,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Account

Peapack Gladstone Financial Corp Edwards Lifesciences Corp Transaction History